NASDAQ:GLMD
Galmed Pharmaceuticals Ltd.
- Stock
Last Close
0.31
26/07 20:00
Market Cap
1.82M
Beta: 1.13
Volume Today
6.14K
Avg: 220.86K
PE Ratio
−0.31
PFCF: −0.15
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 467K - | 1.08M 132.33% | 2.04M 87.83% | |||||||||
cost of revenue | 35K - | 39K 11.43% | 42K 7.69% | 35K 16.67% | 31K 11.43% | |||||||
gross profit | 467K - | 1.08M 132.33% | 2.04M 87.83% | -35K 101.72% | -39K 11.43% | -42K 7.69% | -35K 16.67% | -31K 11.43% | ||||
selling and marketing expenses | ||||||||||||
general and administrative expenses | 7.36M - | 2.48M 66.31% | 3.25M 30.99% | 3.08M 5.18% | 3.80M 23.42% | 4.44M 16.87% | 4.20M 5.50% | 4.13M 1.62% | 5.66M 37.14% | 4.66M 17.75% | ||
selling general and administrative expenses | 7.36M - | 2.48M 66.31% | 3.25M 30.99% | 3.08M 5.18% | 3.80M 23.42% | 4.44M 16.87% | 4.20M 5.50% | 4.13M 1.62% | 5.66M 37.14% | 4.66M 17.75% | 3.89M 16.41% | |
research and development expenses | 7.21M - | 6.66M 7.53% | 7.63M 14.48% | 14.27M 87.06% | 9.65M 32.38% | 8.31M 13.85% | 18.18M 118.69% | 26.08M 43.47% | 27.22M 4.36% | 12.99M 52.26% | 3.57M 72.54% | |
other expenses | -10K - | |||||||||||
cost and expenses | 14.56M - | 9.14M 37.22% | 10.88M 18.96% | 17.35M 59.53% | 13.45M 22.48% | 12.75M 5.18% | 22.38M 75.46% | 30.21M 35.01% | 32.88M 8.84% | 17.65M 46.32% | 7.49M 57.55% | |
operating expenses | 14.56M - | 9.14M 37.22% | 10.88M 18.96% | 17.35M 59.53% | 13.45M 22.48% | 12.75M 5.18% | 22.38M 75.46% | 30.21M 35.01% | 32.88M 8.84% | 17.65M 46.32% | 7.46M 57.73% | |
interest expense | 33K - | 31K 6.06% | 43K 38.71% | 215K 400% | 11K 94.88% | |||||||
ebitda | -14.56M - | -9.13M 37.26% | -10.82M 18.53% | -16.71M 54.39% | -12.13M 27.45% | -10.35M 14.68% | -22.34M 115.96% | -30.17M 35.05% | -32.84M 8.84% | -17.13M 47.85% | -7.46M 56.43% | |
operating income | -14.57M - | -9.14M 37.26% | -10.88M 18.96% | -16.88M 55.24% | -12.36M 26.76% | -10.71M 13.34% | -22.38M 108.83% | -30.21M 35.01% | -32.88M 8.84% | -17.65M 46.32% | -7.49M 57.55% | |
depreciation and amortization | 4K - | 9K 125% | 50K 455.56% | 169K 238% | 239K 41.42% | 387K 61.92% | 35K 90.96% | 39K 11.43% | 42K 7.69% | 525K 1,150% | 31K 94.10% | |
total other income expenses net | -10K - | 18.24M 182,540% | 21.50M 17.83% | 35K 99.84% | 65K 85.71% | 17K 73.85% | 1.92M 11,164.71% | 1.44M 24.86% | 414K 71.23% | -215K 151.93% | 580K 369.77% | |
income before tax | -17.48M - | -9.10M 47.94% | -10.62M 16.70% | -16.85M 58.60% | -12.30M 27.00% | -9.78M 20.47% | -20.46M 109.19% | -28.77M 40.61% | -32.47M 12.85% | -17.87M 44.97% | -6.91M 61.31% | |
income tax expense | 1K - | 1K 0% | 21.24M 2,124,300% | 106K 99.50% | 12.36M 11,564.15% | 75K 99.39% | -1.92M 2,660% | -1.16M 39.53% | -519K 55.30% | 705K 235.84% | ||
net income | -17.48M - | -9.10M 47.94% | -10.62M 16.69% | -16.95M 59.60% | -12.30M 27.45% | -9.86M 19.86% | -18.54M 88.12% | -27.61M 48.91% | -31.95M 15.71% | -18.57M 41.87% | -6.91M 62.78% | |
weighted average shs out | 711.66K - | 688.25K 3.29% | 740.03K 7.52% | 758.31K 2.47% | 832.49K 9.78% | 1.21M 45.25% | 1.41M 16.41% | 1.42M 0.79% | 1.64M 15.59% | 1.68M 2.22% | 2.77M 65.23% | |
weighted average shs out dil | 711.66K - | 688.25K 3.29% | 740.03K 7.52% | 758.31K 2.47% | 832.49K 9.78% | 1.21M 45.25% | 1.41M 16.41% | 1.42M 0.79% | 1.64M 15.59% | 1.68M 2.22% | 2.77M 65.23% | |
eps | -24.57 - | -13.23 46.15% | -14.35 8.47% | -22.36 55.82% | -14.77 33.94% | -8.15 44.82% | -13.17 61.60% | -19.46 47.76% | -19.48 0.10% | -11.08 43.12% | -2.50 77.44% | |
epsdiluted | -24.57 - | -13.23 46.15% | -14.35 8.47% | -22.36 55.82% | -14.77 33.94% | -8.15 44.82% | -13.17 61.60% | -19.46 47.76% | -19.48 0.10% | -11.08 43.12% | -2.50 77.44% |
All numbers in USD (except ratios and percentages)